Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus and Imatinib in Advanced Renal Carcinoma
NCT00331409Phase 2Completed
- Sponsor
- OHSU Knight Cancer Institute
- Start
- Jan 2006
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in renal cell carcinoma (RCC), sponsored by OHSU Knight Cancer Institute. Started Jan 2006; status: completed.
02
Drugs
everolimus
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00331409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00331409.